SLDB Earnings Date: Nov 2, 2026 (Estimated) — Solid Biosciences Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is SLDB's next earnings date?
Solid Biosciences Inc. (SLDB) is expected to report Q3 2026 earnings on Monday, November 2, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.37.
How did SLDB do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Solid Biosciences Inc. posted EPS of -$0.38 versus the -$0.46 estimate, a beat of 17.4%. Revenue was $0. The stock's 1-day post-earnings move was -3.7%.
How much does SLDB stock move after earnings?
SLDB beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.7% (up or down) in the day after earnings.
About Solid Biosciences Inc.
Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene transfer treatment currently in Phase I/II clinical trials, designed to encourage the production of functional dystrophin protein in patients' muscles. The company is also progressing with SGT-003, which represents a next-generation gene transfer therapy intended for DMD. Beyond specific drug candidates, Solid Biosciences is actively developing innovative platform technologies, such as "dual gene expression," a technique that allows for multiple therapeutic genes to be bundled into a single viral vector, and researching new capsid designs. The company maintains a strategic alliance through a collaboration and license agreement with Ultragenyx Pharmaceutical Inc., focusing on the joint development and market introduction of novel gene therapies for Duchenne Muscular Dystrophy. Founded in 2013, Solid Biosciences Inc. conducts its operations from its headquarters in Cambridge, Massachusetts.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.46 | -0.38 | +17.39% | $0 | ✅ Beat | -3.67% | +4.25% | +17.68% |
| 2026-05-12 | Q1 2026 | -0.43 | -0.52 | -20.93% | $0 | ❌ Miss | -4.40% | -21.24% | -6.48% |
| 2026-03-19 | Q4 2025 | -0.52 | -0.53 | -1.92% | $0 | ❌ Miss | -1.26% | +8.57% | +19.24% |
| 2025-11-03 | Q3 2025 | -0.43 | -0.48 | -11.63% | $0 | ❌ Miss | -15.29% | -20.19% | -0.19% |
| 2025-08-12 | Q2 2025 | -0.50 | -0.42 | +16.00% | $0 | ✅ Beat | +10.60% | -3.97% | -12.09% |
| 2025-03-06 | Q4 2024 | -0.72 | -1.00 | -38.89% | $0 | ❌ Miss | -1.45% | -6.45% | -43.36% |
| 2024-08-13 | Q2 2024 | -0.67 | -0.61 | +8.96% | $0 | ✅ Beat | +14.54% | +27.98% | +5.90% |
| 2024-05-15 | Q1 2024 | -0.64 | -0.64 | +0.00% | $0 | ➖ Inline | -2.71% | -14.56% | -14.56% |
Showing last 8 quarters.